Showing 331-340 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Novel Cell-free DNA and RNA Dynamics in Islet Transplant | Beckman Research Institute of the City of Hope | Fouad Kandeel | Cures | 01-August-2026 to 31-July-2028 | $600,000.00 |
| Pilot Clinical Trial of Allogenic Islet Transplantation under the Abdominal Anterior Rectus Sheath for Advancing Treatment of Type 1 Diabetes | Beckman Research Institute of the City of Hope | Fouad Kandeel | Cures | 01-October-2026 to 30-September-2028 | $800,000.00 |
| Modulation of beta cell mRNA Translation in Type 1 Diabetes | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-September-2024 to 31-March-2027 | $444,138.25 |
| Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass | Beckman Research Institute of the City of Hope | Debbie Thurmond | Cures | 01-October-2025 to 30-September-2028 | $1,050,000.00 |
| GLUT1 Inhibition in type 1 diabetes | Beckman Research Institute of the City of Hope | Alberto Pugliese | Cures | 01-November-2022 to 31-July-2026 | $494,072.25 |
| A novel approach to overcome innate immunity in beta-cell replacement therapy for type 1 diabetes | Baylor Research Institute | Bashoo Naziruddin | Cures | 01-January-2025 to 31-December-2027 | $749,769.68 |
| Unraveling the Influence of Obesity on Progression Along Preclinical Stages of Type 1 Diabetes | Baylor College of Medicine | Maria Redondo | Cures | 01-June-2025 to 31-May-2028 | $1,124,188.00 |
| Understanding Disease Mechanisms Underlying Type 1 Diabetes | Baylor College of Medicine | Ashok Balasubramanyam | Cures | 01-November-2024 to 31-October-2027 | $967,091.04 |
| Phase II Study of Oral HLA DQ8 Inhibitor in Adults with Type-I Diabetes | Aurimi Therapeutics | Nandan Padukone | Cures | 01-September-2026 to 31-August-2030 | $1,900,000.00 |
| Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-September-2023 to 31-May-2027 | $2,852,490.70 |